What is 21 CFR Part 11?The FDA (Food and Drug Administration) provides regulations for the health industry. The central set of regulations for Laboratories is defined in the Good Laboratory Practice (GLP) rules. Any Laboratory that executes clinical studies and trials submit their results to the FDA for further inspection. Therefore, the FDA controls whether an institution is GLP-compliant or not. To facilitate the
submission of results, the FDA approached the electronic submission of records. To
ensure reliable submission, exchange, generation and maintenance of data, the FDA
established requirements and regulations under the title 21 of the CFR
(Code of Federal Regulations) within its Part 11. This set of regulations
establishes baseline standards for electronic records managed by computer systems.
Part 11 applies to systems that create, modify and maintain electronic data.
Regarding the usage of computer systems, it is important to emphasize that
compliance within an organization can only be established when the complete
organizational process meets the requirements. Therefore, compliance can only
exist for both components together—the software itself AND the organizational
environment.
|
|
21 CFR Part 11 Requirements:Key requirements include:
|
|
Why does CTL care about GLP?CTL takes pride in being the leader in Elispot technology. CTL Laboratories, LLC is the NIH Immune Tolerance Network's reference laboratory for clinical trials and has been providing contract research services for major pharmaceutical companies. CTL encourages prospective customers to take advantage of our knowledge, experience
and expertise. Please contact us for detailed discussions on key GLP requirements.
We would be happy to supply you with the information you need.
|
|